Rocket Lab's Neutron Debut Slides to 2027 as Composite Flaw Forces a Rethink on Wall Street
Published on 10/16/2026 at 14:51 | Editorial boerse-global.de
Rocket Lab has pushed the maiden flight of its Neutron medium-lift rocket from the fourth quarter of 2026 into 2027, a schedule slip that has prompted a fresh round of price-target cuts from analysts and renewed scrutiny of the company's path to profitability.
The delay traces back to air pockets trapped between the carbon-fiber layers in the forward fuel tank dome of the first stage. The problem follows an earlier setback in January 2026, when a tank ruptured during a hydrostatic pressure test, forcing Rocket Lab to rework both its design and manufacturing processes. CEO Peter Beck said a rear dome built under the revised procedure has since passed inspection, and a new forward component is now in production.
Analysts Trim Targets but Keep Their Ratings
Clear Street lowered its price target on the stock to $105 from $129, maintaining a Buy rating. KeyBanc cut its own target to $100 from $135 while keeping an Overweight stance. The reduced targets reflect mounting uncertainty and a later timeline for earnings, even as both firms signal that their broader thesis on the company remains intact.
Not everyone on the Street has moved. Andres Sheppard of Cantor Fitzgerald reaffirmed his Buy rating and a $122 price target following the announcement, pointing to persistently strong long-term demand for orbital transport services.
Should investors sell immediately? Or is it worth buying Rocket Lab?
A Steep Drawdown in the Shares
The market's reaction has been sharp. The stock closed at EUR 49.30 in German trading, down 7.2% on the day, leaving it 63% below its 52-week high. Over a seven-day stretch the shares have shed 19%, and they were quoted at EUR 49.05 in more recent trading, a modest 0.5% daily decline.
A Management Sale Draws Attention
Alongside the operational hurdles, a transaction from the executive suite has come under the microscope. On October 1, CFO Adam Spice sold 140,157 shares for a total of $9,925,448, following the exercise of the same number of options at a strike price of $1.09 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan that Spice set up on June 3. Such plans carry out transactions automatically according to fixed criteria, independent of short-term company news, though the disclosure landed in a market already on edge over the Neutron program.
What's Riding on Neutron
Neutron is designed to carry up to 13,000 kilograms to low Earth orbit, putting it in direct competition with SpaceX's Falcon 9. Rocket Lab's existing Electron rocket, with a payload of roughly 300 kilograms, is bumping against natural volume limits, making the larger vehicle the company's central growth engine for years to come.
The pivotal question for investors is whether the carbon composite issues are genuinely isolated or the start of a drawn-out chain reaction. A demanding test program still lies ahead, including qualification of the first stage and its nine Archimedes engines, which are meant to deliver about 6.45 million Newtons of liftoff thrust. Engine and first-stage qualification, along with the launch campaign at Wallops Island, remain outstanding. If cryogenic and hydrostatic load tests wrap up without further incidents by the first quarter of 2027, the schedule would hold. Every additional month of delay ties up development resources and pushes back the first commercial flight that long-term profitability depends on.
A Record Backlog Underpins the Bull Case
The optimistic scenario rests on the underlying strength of the existing business. Rocket Lab reported a record order backlog of $2.36 billion at the end of the second quarter of 2026, up 137% year over year. More than 90 launches are under contract across all programs, and the proven Electron rocket has strung together 56 consecutive successful missions. Several analysts view the pullback as overdone, citing a persistent global shortage of launch capacity.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
Risks to the Financial Foundation
On the other side, continued technical obstacles could meaningfully worsen the outlook. The Neutron debut had already been postponed multiple times before this latest announcement, after an initial target of 2024. Should delamination or material weaknesses resurface during upcoming pressure tests of the newly laminated dome, the launch could slide deep into the second half of 2027 or beyond. That kind of slippage would overshadow the $250 million to $265 million in third-quarter 2026 revenue projected for the group in subsequent quarters and weigh on 2027 estimates. Heavy upfront spending on Archimedes engine qualification and ground infrastructure in Virginia is draining liquidity, and a further delay to market entry in the lucrative medium-lift segment risks satellite operators taking their contracts elsewhere.
What to Watch Next
The next decisive milestone is completion of the dome by the end of 2026. If the first stage is assembled and integrated without flaws in the first quarter of 2027, the market finally gets the reliable launch date it has been waiting for. Until then, the stock's recent level is the line to hold: defending it keeps the broader upside story for the coming year alive, while a continued correction and fading confidence in management's timelines could set up another test of the yearly lows.
Ad
Rocket Lab Stock: New Analysis - 16 October
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
